BioNTech SE (BNTX) Enterprise Value Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) Enterprise Value Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.44% |
| Sep 30, 2025 | 7.45% |
| Jun 30, 2025 | 14.69% |
| Mar 31, 2025 | 12.79% |
| Dec 31, 2024 | -0.73% |
| Sep 30, 2024 | -7.04% |
| Jun 30, 2024 | -9.95% |
| Mar 31, 2024 | -25.24% |
| Dec 31, 2023 | -24.09% |
| Sep 30, 2023 | -1,191.77% |
| Jun 30, 2023 | -1,038.15% |
| Mar 31, 2023 | -593.43% |
| Dec 31, 2022 | -504.70% |
| Sep 30, 2022 | -206.65% |
| Jun 30, 2022 | 15.45% |
| Mar 31, 2022 | -82.14% |
| Dec 31, 2021 | -47.71% |
| Dec 31, 2020 | -178.69% |
| Dec 31, 2019 | -22.88% |